ARASTATIN
LIVE

Serial Number

79448312

Owner

Araris Biotech AG

Filing Date

Nov 26, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ARASTATIN Trademark

Serial Number: 79448312

ARASTATIN is a trademark filed by Araris Biotech AG on November 26, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Araris Biotech AG (4 trademarks)

Riedhofstrasse 11

Entity Type: 98

Trademark Details

Filing Date

November 26, 2025

Registration Date

Not Registered

Goods & Services

Chemical, biochemical, biological and molecular genetic products intended for laboratory analysis, industry and science; bioactive reagents and compounds; peptides, peptide derivatives, proteins, glycans, nucleotides, lipids, antibodies, antibody-active principle conjugates, antibody fragments, antibody derivatives, nucleic acids, DNA, vectors; chemical, biochemical, biological, biotechnological and molecular genetic preparations for industrial and scientific use; chemical, biological, biotechnological and molecular genetic preparations, namely polypeptides and proteins for reagent development or production for industrial and scientific applications; biological preparations, namely polypeptides, peptide derivatives or proteins for laboratories and analysis for industrial and scientific applications; chemical and biochemical substances for use in the manufacture of pharmaceuticals.

Pharmaceutical products, medical preparations; pharmaceuticals and medical preparations in the field of cancer therapy; biopharmaceuticals and medical preparations in the field of active antibody conjugates; chemical, biological, molecular genetic and biochemical and biopharmaceutical products for medical, pharmaceutical use, namely peptides, peptide derivatives, proteins, antibodies, active antibody conjugates, antibody fragments, antibody derivatives, nucleic acids, DNA, vectors; pharmaceutical products and substances for the treatment of diseases and preparations for medical treatments.

Scientific and technological services as well as research work and design services relating thereto, namely, services provided by scientists dedicated to the chemical and technological study of biological molecules; scientific, medical, biological, molecular genetic, chemical, pharmaceutical and technological research, in the field of biochemistry or pharmacy; services of a biochemical or pharmaceutical laboratory; industrial analysis and research services; development and experimentation of medicines; conducting preclinical and clinical trials; laboratory services for the benefit of third parties; scientific advisory services in the biochemical, biological and molecular genetic fields; scientific advice for the pharmaceutical industry sector; analysis services for medical and pharmaceutical research services in connection with the treatment of individuals, included in class 42; provision of scientific research information and results.

Providing information with respect to business contacts for research projects.

Filing History

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 11, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jun 11, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 28, 2026 RFCR
NON-FINAL ACTION WRITTEN
Apr 27, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 23, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 22, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 22, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 16, 2026 REPR